Growth Stage
Also known as Growth-Stage VC, Late-Stage Venture, Growth Equity
Growth stage is the late-venture window, typically Series C and beyond, where companies have proven unit economics and the investment thesis is scale, not survival. PitchBook-NVCA classifies these as late-stage VC and venture growth, with Cooley data showing median Series C pre-money valuations of $367M in Q4 2025.
In depth
Growth stage starts where scale becomes the dominant risk. The company has cleared product-market fit, the GTM motion is repeatable, and the remaining question is whether the business can compound revenue at the rate implied by its valuation. The financial profile reads more like a public company: monthly forecasting, defined sales territories, real CFO discipline.
The investor base shifts at growth stage. Early-stage venture funds typically reserve capital for pro-rata participation but rarely lead. The lead role moves to crossover funds, growth-equity firms, and large multi-stage venture firms with dedicated growth platforms. Many growth-stage rounds are partly primary and partly secondary, with the lead buying both newly issued shares and existing shares from early investors or founders.
The 2025 growth-stage market is bifurcated. AI infrastructure and applied-AI rounds clear at unusually high valuations: Cooley reported the median Series C pre-money valuation more than doubled from $175M in Q3 to $367M in Q4 2025, driven by a small number of large AI deals. Non-AI growth-stage companies face a tougher market, with longer fundraising timelines and more aggressive terms.
Why it matters
Growth stage is where venture funds generate most of their realized DPI. Early-stage TVPI moves on Series B and C markups; DPI moves on growth-stage exits and pre-IPO secondary sales. A 2017-vintage early-stage fund that produces top-quartile DPI by year 10 almost always did so by holding through to growth-stage rounds where secondary windows opened.
For LPs evaluating funds, the question is exit timing. Growth-stage rounds in 2025 are increasingly used to fund the bridge to a delayed IPO window rather than to capitalize the next leg of growth. Companies are staying private longer, with the NVCA 2026 Yearbook documenting a venture industry in transition where capital concentrated into AI deals (65% of $320B deployed in 2025) and 859 unicorns remained in the private market backlog.
Worked example
A growth-equity fund writes a $40M Series D check at $1.2B pre-money, $1.24B post-money, with $10M of that round used to purchase existing shares from early investors and the founding team.
Primary investment: $30M
Secondary purchase: $10M
Total deployed: $40M
Position size after round: $40M / $1.24B = 3.2%
If company exits at $5B in 5 years:
Exit value: $5B × 3.2% = $160M
MOIC: $160M / $40M = 4.0x
Approximate IRR: ~32% over 5 years
The position produces 4.0x MOIC at the modeled exit, the kind of outcome growth-stage funds underwrite as a base case. The early shareholders who sold $10M into the secondary block crystallize part of their gain years before the eventual exit, accelerating DPI for whichever fund held that position.
Frequently asked
What counts as growth stage?
Most firms treat Series C and beyond as growth, with Series B sitting on the boundary. PitchBook-NVCA tracks late-stage VC (Series C+) separately from venture growth (large pre-IPO rounds, usually $100M+). The defining feature is not the round number but the company's stage: established revenue, working unit economics, and a credible exit path within 3-5 years.
What kind of companies raise growth-stage capital?
Companies with $25M+ ARR, gross margins above 60% for software, and net retention above 110%. Growth-stage investors care less about TAM stories and more about payback period, Rule of 40, and how much capital is required to compound revenue. Pure growth-at-all-costs companies stopped clearing growth-stage diligence in 2023.
How is growth-stage different from venture capital?
Risk-return shape. Early-stage venture relies on a small number of 50-100x outcomes to produce returns. Growth-stage relies on most positions clearing 2-3x with a smaller number producing 5-10x. Cambridge Associates benchmarks show growth-stage funds typically deliver lower TVPI but higher DPI and faster distributions than early-stage venture.
What is a typical growth-stage round?
Carta data puts median Series C raises at $50-100M and Series D+ rounds at $75M-$300M. The 2025 AI premium has pushed top-decile growth-stage rounds well over $500M. Cooley's Q4 2025 report shows median Series C pre-money valuations jumped from $175M to $367M between Q3 and Q4 2025.
Who leads growth-stage rounds?
Crossover funds (Tiger, Coatue, Altimeter), dedicated growth equity firms (Insight, General Atlantic, TA), sovereign-affiliated pools, and the growth arms of large multi-stage venture firms. Many growth-stage leads buy primary stock and also clear secondary blocks from early shareholders in the same transaction.